Peter Steven St - Net Worth and Insider Trading

Peter Steven St Net Worth

The estimated net worth of Peter Steven St is at least $3 Million dollars as of 2024-11-10. Peter Steven St is the PRESIDENT AND CEO of Aratana Therapeutics Inc and owns about 603,623 shares of Aratana Therapeutics Inc (PETX) stock worth over $3 Million. Details can be seen in Peter Steven St's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Steven St has not made any transactions after 2018-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Peter Steven St

Peter Steven St Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Steven St owns 5 companies in total, including Aratana Therapeutics Inc (PETX) , Altimmune Inc (ALT) , and Verastem Inc (VSTM) among others .

Click here to see the complete history of Peter Steven St’s form 4 insider trades.

Insider Ownership Summary of Peter Steven St

Ticker	Comapny	Transaction Date	Type of Owner
PETX	Aratana Therapeutics Inc	2018-12-17	director & PRESIDENT AND CEO
ALT	Altimmune Inc	2009-03-09	director
VSTM	Verastem Inc	2012-01-26	other: Former 10% stockholder
		2008-06-15	director & President
		2011-02-02	10 percent owner

Peter Steven St Latest Holdings Summary

Peter Steven St currently owns a total of 1 stock. Peter Steven St owns 603,623 shares of Aratana Therapeutics Inc (PETX) as of December 17, 2018, with a value of $3 Million.

Latest Holdings of Peter Steven St

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PETX	Aratana Therapeutics Inc	2018-12-17	603,623	4.92	2,969,825

Holding Weightings of Peter Steven St

Peter Steven St Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Steven St has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 46,094 shares on December 17, 2018, which brought Peter Steven St around $269,650.

Insider Trading History of Peter Steven St

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Steven St Trading Performance

GuruFocus tracks the stock performance after each of Peter Steven St's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Steven St is 130.14%. GuruFocus also compares Peter Steven St's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Steven St within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Steven St's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Steven St

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	21.33
Relative Return to S&P 500(%)	15.41

Peter Steven St Ownership Network

Ownership Network List of Peter Steven St

No Data

Ownership Network Relation of Peter Steven St

Peter Steven St Owned Company Details

What does Aratana Therapeutics Inc do?

Who are the key executives at Aratana Therapeutics Inc?

Peter Steven St is the director & PRESIDENT AND CEO of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Aratana Therapeutics Inc (PETX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aratana Therapeutics Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Peter Steven St is the director of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Peter Steven St made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 15,711 shares made by David Drutz ,

In summary, during the past 3 months, insiders sold 16,011 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 16,011 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 300 shares were bought by its insiders, resulting in a net sale of 15,711 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Peter Steven St is the other: Former 10% stockholder of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Peter Steven St made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 668 shares made by Daniel Calkins , a net sale of 20,888 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 2,695 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,695 shares. During the past 18 months, 33,122 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,122 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verastem Inc Insider Transactions

No Available Data

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Peter Steven St is the director & President of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

Peter Steven St is the 10 percent owner of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, Peter Steven St made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .

In summary, during the past 3 months, insiders sold 500 shares of Pacira BioSciences Inc (PCRX) in total and bought 20,976 shares, with a net purchase of 20,476 shares. During the past 18 months, 224,391 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 203,415 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacira BioSciences Inc Insider Transactions

No Available Data

Peter Steven St Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Steven St. You might contact Peter Steven St via mailing address: Mpm Capital, 200 Clarendon Street 54th Floor, Boston Ma 02116.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.